QT
CRL icon

Quantamental Technologies’s Charles River Laboratories CRL Stock Holding History

Quantamental Technologies’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-1,297
Closed -$278K – 531
2022
Q2 		$278K Sell
1,297
-240
-16% -$58.6K 0.13% 283
2022
Q1 		$436K Buy
+1,537
New +$474K 0.25% 157
2020
Q1 		– Sell
-1,636
Closed -$250K – 183
2019
Q4 		$250K Buy
+1,636
New +$227K 0.13% 305
2019
Q2 		– Sell
-2,005
Closed -$291K – 1519
2019
Q1 		$291K Buy
2,005
+900
+81% +$118K 0.13% 246
2018
Q4 		$125K Buy
+1,105
New +$138K 0.07% 475

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Quantamental Technologies's CRL Position: Q3 2022 in Review

Quantamental Technologies sold out of Charles River Laboratories (CRL) in Q3 2022, closing a stake of 1,297 shares — an estimated $278K sold.

Quantamental Technologies first reported a position in CRL in Q4 2018 and held it in 5 quarters. The position peaked at $436K in Q1 2022. 582 funds tracked by Wall St. Rank hold CRL as of Q3 2022.

  • Quantamental Technologies reported no remaining Charles River Laboratories position as of Q3 2022 after selling out during the quarter.
  • Quantamental Technologies sold 1,297 Charles River Laboratories shares in Q3 2022, an estimated $278K.
  • Quantamental Technologies first reported a position in Charles River Laboratories in Q4 2018 and held it in 5 quarters.
  • Quantamental Technologies's Charles River Laboratories position peaked at $436K in Q1 2022.
  • 582 funds tracked by Wall St. Rank held Charles River Laboratories as of Q3 2022.

Based on Quantamental Technologies's 13F filing for Q3 2022, filed 14 Nov 2022.